SCHEMBL25925802

SCHEMBL25925802

Cc1noc(/N=N/c2c(O)ccc(/N=N/c3snc4cccnc34)c2O)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.35
MEN1 O00255 9/20 0.35
KMT2A Q03164 9/20 0.35
TDP1 Q9NUW8 7/20 0.35
HTT P42858 6/20 0.35
SMN1; SMN2 Q16637 6/20 0.35
L3MBTL1 Q9Y468 5/20 0.35
LMNA P02545 3/20 0.35
ALDH1A1 P00352 1/20 0.35
KCNH2 Q12809 1/20 0.35
MAPK1 P28482 7/20 0.34
OPRK1 P41145 4/20 0.34
AGTR1 P30556 2/20 0.34
HKDC1 Q2TB90 1/20 0.34
BRD4 O60885 1/20 0.34
CYP1A2 P05177 2/20 0.33
HIF1A Q16665 2/20 0.33
KDM4E B2RXH2 4/20 0.32
NPC1 O15118 2/20 0.32
HSP90AA1 P07900 5/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25925806 0.86
SCHEMBL25925843 0.85 MEN1 (0.31) MAPTMEN1KMT2ATDP1HTT
SCHEMBL25925804 0.79
SCHEMBL25925818 0.79 MEN1 (0.42) MAPTMEN1KMT2ATDP1HTT
SCHEMBL25925787 0.79 BRD4 (0.37) MAPTMEN1KMT2ATDP1HTT
SCHEMBL25925798 0.77
SCHEMBL25927255 0.77
SCHEMBL25925792 0.76 MEN1 (0.33) MAPTMEN1KMT2ACYP1A2HIF1A
SCHEMBL25925762 0.73 MAPT (0.31) MAPTMEN1KMT2ATDP1HTT
SCHEMBL25925841 0.69 MEN1 (0.34) MAPTMEN1KMT2ATDP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 MAPT 2/4885MEN1 67/4885KMT2A 1814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.